Integrative analysis identifies glioblastoma biomarkers, suggesting new paths for personalized treatment strategies.
This robust integrative machine learning approach for biomarker discovery in GBM supports the development of more personalized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Nisar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: